Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Jul-24 5:45 PM View:  | Igm Biosciences, Inc. (IGMS) | 25-Jul-24 | Option Exercise | 15,132 | $1.39 | $21,033.50 | 757% 2.0K to 17.13K | |
| 29-Jul-24 5:45 PM View: | Igm Biosciences, Inc. (IGMS) | 25-Jul-24 | Planned Option Sale | 15,132 | $14.00 | $211,848.00 | (88%) 17.13K to 2.0K | |
| 05-Jun-24 4:08 PM View: | Springworks Therapeutics, I... (SWTX) | 03-Jun-24 | Sale (Planned) | 4,648 | $40.03 | $186,048.00 | (53%) 8.74K to 4.09K | |
| 17-May-24 4:04 PM View: | Springworks Therapeutics, I... (SWTX) | 16-May-24 | Grant | 4,095 | -- | -- | 88% 4.65K to 8.74K | |
| 21-Jul-23 4:13 PM View: | Springworks Therapeutics, I... (SWTX) | 19-Jul-23 | Sale (Planned) | 2,418 | $29.31 | $70,875.90 | (34%) 7.07K to 4.65K | |
| 22-Jun-23 4:06 PM View: | Springworks Therapeutics, I... (SWTX) | 20-Jun-23 | Sale (Planned) | 2,400 | $26.92 | $64,603.20 | (25%) 9.47K to 7.07K | |
| 25-May-23 4:26 PM View: | Springworks Therapeutics, I... (SWTX) | 24-May-23 | Grant | 4,648 | -- | -- | 96% 4.82K to 9.47K | |
| 16-Mar-23 10:00 PM View: | Springworks Therapeutics, I... (SWTX) | 15-Mar-23 | Sale | 1,106 | $31.50 | $34,841.30 | (19%) 5.92K to 4.82K | |
| 20-May-22 5:40 PM View: | Springworks Therapeutics, I... (SWTX) | 19-May-22 | Grant | 4,818 | -- | -- | 436% 1.11K to 5.92K | |
| 11-Aug-21 9:37 PM View: | Igm Biosciences, Inc. (IGMS) | 09-Aug-21 | Market Sale (Planned) | 1,000 | $80.00 | $80,000.00 | (33%) 3.0K to 2.0K | (6%) |
| 20-Jul-21 8:43 PM View: | Erasca, Inc. (ERAS) | 20-Jul-21 | Private Purchase | 6,000 | $16.00 | $96,000.00 | 100% 0 to 6.0K | |
| 03-Jun-21 8:29 PM View: | Igm Biosciences, Inc. (IGMS) | 01-Jun-21 | Market Sale (Planned) | 2,000 | $80.00 | $160,000.00 | (40%) 5.0K to 3.0K | (1%) |
| 21-May-21 4:32 PM View: | Springworks Therapeutics, I... (SWTX) | 20-May-21 | Grant | 1,106 | -- | -- | 23% 4.89K to 6.0K | |
| 20-Sep-19 9:10 PM View: | Igm Biosciences, Inc. (IGMS) | 18-Sep-19 | Purchase | 5,000 | $18.31 | $91,550.00 | 100% 0 to 5.0K | |
| 13-Nov-15 5:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-15 | Option Exercise | 22,000 | $9.38 | $206,280.00 | 25% 87.68K to 109.68K | |
| 13-Nov-15 5:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-15 | Market Option Sale | 22,000 | $34.63 | $761,867.00 | (20%) 109.68K to 87.68K | (9%) |
| 13-Nov-15 5:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-15 | Market Sale | 1,108 | $34.63 | $38,370.40 | (1%) 87.68K to 86.58K | (9%) |
| 21-Aug-15 7:22 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Aug-15 | Grant | 75,000 | -- | -- | 698% 10.74K to 85.74K | |
| 04-May-15 4:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Apr-15 | Grant | 7,980 | -- | -- | 399% 2.0K to 9.98K | |
| 30-Oct-15 6:09 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Aug-14 | Market Purchase | 400 | $10.75 | $4,300.00 | < 1% 87.28K to 87.68K | 252% |
| 30-Oct-15 6:09 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Nov-13 | Market Purchase | 500 | $10.10 | $5,050.00 | < 1% 86.78K to 87.28K | 275% |
| 30-Oct-15 6:09 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Sep-13 | Market Purchase | 64 | $13.70 | $876.80 | < 1% 86.72K to 86.78K | 177% |
| 30-Oct-15 6:09 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 18-Sep-13 | Purchase | 800 | $14.75 | $11,800.00 | < 1% 85.92K to 86.72K |